 "Gautam Gambhir Foundation guilty of stocking drugs: Drug Controller to HC")
The Gautam Gambhir Foundation has been found guilty of unauthorisedly stocking, procuring and distributing Fabiflu medicine to COVID-19 patients, the Delhi High Court was informed by the Delhi government's drug controller on Thursday.
The drug controller submitted that action will be taken without delay against the foundation, drug dealers as also in other such cases which would be brought to its notice.
MLA Praveen Kumar has also been found guilty for similar offences under the Drugs and Cosmetics Act, the court was informed.
The court asked the drug controller to file status reports on further progress in these cases within six weeks and listed the matter for hearing on July 29.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app